Anika Therapeutics names Richard Hague chief commercial officer: 5 things to know

Anika Therapeutics has appointed Richard Hague as chief commercial officer.

Advertisement

Here are five things to know:

 

1. Mr. Hague has more than 30 years of commercial leadership experience in the life sciences sector.

 

2. In his new role, Mr. Hague is responsible for leading the company’s global commercial strategy.

 

3. He most recently served as vice president of sales and marketing at TEI Medical.

 

4. He has also previously served as VP of sales, marketing and commercial operations at Sanofi Biosurgery.

 

5. Anika Therapeutics is a global, integrated orthopedic medicines company focusing on developing therapeutic pain management solutions.

 

More articles on devices:
Zimmer Biomet tackles Q3 after merger; sales up 59%: 10 key notes
Miliman report analyzes procedures for lumbar spinal stenosis
ReVivo Medical receives $225k grant for spine surgery device: 5 takeaways

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.